Sort by
Refine Your Search
-
processes. We welcome applications from recent PhD graduates who are interested in these or related fields, particularly those who may bring a new technology or perspective to bear on the work in the lab
-
processes; and stewards the fellows’ experience from recruitment through selection, residency, and alumni engagement. In close collaboration with the Associate Dean, the Dean of the Harvard Radcliffe
-
; familiarity with large language models or natural language processing is a plus Additional Qualifications If visa sponsorship is needed, Harvard retains the discretion to determine which visa status is
-
decisions and therapies to treat these diseases. In addition to contributing to or leading the publication of research articles, this role provides the opportunity to present your research to regulatory
-
will work with Dr. Bean and a team of postdoctoral researchers in the Bean lab to do early-stage drug discovery to find novel compounds to treat pain, epilepsy, and multiple sclerosis by modulating
-
Instructions Please submit the following materials through the ARIeS portal. The application review process will begin on MARCH 16, 2026 and will continue until the position is filled. 1. Cover letter. 2. Resume
-
or neuromodulators, peripheral nerve surgery, neural interfacing models Track record of disseminating research through impactful publications and presentations (at least three first author publications) Desire to work
-
Details Title Postdoctoral Fellowship Position in Visual Computing at Harvard University School Harvard John A. Paulson School of Engineering and Applied Sciences Department/Area Computer Sciences
-
Process: Interested candidates should submit a cover letter, CV, a brief research proposal, and two to three references’ names and contact information. Applications will be reviewed on a rolling basis until
-
for genome sequencing data to enhance our understanding of disease processes including cancer and brain-related diseases. Areas of interest include: Identification of mosaic mutations in non-tumor cells and